Glycemic outcomes of Advanced Hybrid Closed Loop system in children and adolescents with Type 1 Diabetes, previously treated with Multiple Daily Injections (MiniMed 780G system in T1D individuals, previously treated with MDI)

A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial

(2021) Richard M Bergenstal et al.   LANCET

One Year Real-World Use of the Control-IQ Advanced Hybrid Closed-Loop Technology

(2021) Marc D. Breton et al.   Diabetes Technology & Therapeutics

Rapid Improvement in Time in Range After the Implementation of an Advanced Hybrid Closed-Loop System in Adolescents and Adults with Type 1 Diabetes

(2021) Pilar Isabel Beato-Víbora et al.   Diabetes Technology & Therapeutics

10-Day structured initiation protocol from multiple daily injection to hybrid closed-loop system in children and adolescents with type 1 diabetes

(2020) Goran Petrovski et al.   ACTA DIABETOLOGICA

97-LB: Safety and Glycemic Outcomes of the MiniMed Advanced Hybrid Closed-Loop (AHCL) System in Subjects with T1D

(2020) ANDERS L. CARLSON et al.   DIABETES

Closed-loop control in insulin pumps for type-1 diabetes mellitus: safety and efficacy

(2020) Julia Fuchs et al.   Expert Review of Medical Devices

A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes

(2020) Marc D. Breton et al.   NEW ENGLAND JOURNAL OF MEDICINE

Closed-Loop Insulin Therapy Improves Glycemic Control in Adolescents and Young Adults: Outcomes from the International Diabetes Closed-Loop Trial

(2020) Elvira Isganaitis et al.   Diabetes Technology & Therapeutics

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

(2019) Tadej Battelino et al.   DIABETES CARE

Real world hybrid closed‐loop discontinuation: Predictors and perceptions of youth discontinuing the 670G system in the first 6 months

(2019) Laurel H. Messer et al.   PEDIATRIC DIABETES

Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis

(2018) Eleni Bekiari et al.   BMJ-British Medical Journal

Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis

(2018) Eleni Bekiari et al.   BMJ-British Medical Journal

Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes

(2018) Linda A. DiMeglio et al.   PEDIATRIC DIABETES

6. Glycemic Targets: Standards of Medical Care in Diabetes—2019

(2018)   DIABETES CARE

Safety Evaluation of the MiniMed 670G System in Children 7–13 Years of Age with Type 1 Diabetes

(2018) Gregory P. Forlenza et al.   Diabetes Technology & Therapeutics

Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial

(2018) Martin Tauschmann et al.   LANCET

Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials

(2017) Alanna Weisman et al.   Lancet Diabetes & Endocrinology

Variability of Insulin Requirements Over 12 Weeks of Closed-Loop Insulin Delivery in Adults With Type 1 Diabetes

(2016) Yue Ruan et al.   DIABETES CARE

Evaluating the Experience of Children With Type 1 Diabetes and Their Parents Taking Part in an Artificial Pancreas Clinical Trial Over Multiple Days in a Diabetes Camp Setting

(2016) Alda Troncone et al.   DIABETES CARE

Coming of age: the artificial pancreas for type 1 diabetes

(2016) Hood Thabit et al.   DIABETOLOGIA

Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes

(2016) Richard M. Bergenstal et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry

(2015) Kellee M. Miller et al.   DIABETES CARE